Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
73.1M
-
Number of holders
-
176
-
Total 13F shares, excl. options
-
41.8M
-
Shares change
-
+636K
-
Total reported value, excl. options
-
$271M
-
Value change
-
+$4.34M
-
Put/Call ratio
-
0.88
-
Number of buys
-
72
-
Number of sells
-
-75
-
Price
-
$6.49
Significant Holders of Mind Medicine (MindMed) Inc. - Common Stock (MNMD) as of Q2 2025
218 filings reported holding MNMD - Mind Medicine (MindMed) Inc. - Common Stock as of Q2 2025.
Mind Medicine (MindMed) Inc. - Common Stock (MNMD) has 176 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 41.8M shares
of 73.1M outstanding shares and own 57.12% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (5.8M shares), Commodore Capital LP (5M shares), Blackstone Inc. (3.59M shares), MARSHALL WACE, LLP (3.42M shares), Driehaus Capital Management LLC (3.09M shares), Deep Track Capital, LP (2.5M shares), Octagon Capital Advisors LP (2.13M shares), VANGUARD GROUP INC (1.81M shares), STATE STREET CORP (1.81M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.73M shares).
This table shows the top 176 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.